Delivery Order SPE2DB22D2211-SPE2DB25FSFQE
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $5,248.48 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors. This firm fixed-price delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a competitively awarded non-set-aside contract. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $4,275.96 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed price delivery order, which is scheduled for completion by September 5, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $5,103.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on September 22, 2025, with completion scheduled for September 23, 2025. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The contract was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $8,842.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on September 10, 2025, with completion targeted for September 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The award represents a child contract action under...
- The Defense Logistics Agency awarded a $18,566.54 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.71 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injectors on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $39,096.11 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on August 26, 2025. This firm fixed-price, competitively awarded contract (no set-aside) specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $20,598.62 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injectors. The contract is set to be completed by September 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,370.16 on August 8, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors under a firm fixed-price contract. The award was competitively procured with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,525.88 on April 24, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of April 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFQEDelivery Order
The Defense Logistics Agency awarded a $7,625.80 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injectors. This firm fixed-price, competitively awarded contract (without set-aside designation) is scheduled for completion by September 24, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial IDC vehicle enables flexible delivery of brand-name and generic medications, specialty drugs, vaccines, and medical supplies across multiple therapeutic domains. This award for Zepbound—a GLP-1 receptor agonist used for weight management—reflects the company's ongoing role in supporting federal medical supply requirements through its established relationship with the Defense Logistics Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 9/23/25 |